Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
Metabolic diseases are risk factors for severe Coronavirus disease (COVID-19), which have a close relationship with metabolic dysfunction-associated fatty liver disease (MAFLD). To evaluate the presence of MAFLD and fibrosis in patients with COVID-19 and its association with prognosis. Retrospective...
Saved in:
| Published in: | Digestive and liver disease Vol. 53; no. 5; pp. 525 - 533 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Netherlands
Elsevier Ltd
01.05.2021
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd |
| Subjects: | |
| ISSN: | 1590-8658, 1878-3562, 1878-3562 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!